PHK
RVMD icon

Point72 Hong Kong’s Revolution Medicines RVMD Stock Holding History

Point72 Hong Kong’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,998
Closed -$39K – 2360
2022
Q2 		$39K Buy
+1,998
New +$38.9K ﹤0.01% 1424
2022
Q1 		– Sell
-2,485
Closed -$63K – 2265
2021
Q4 		$63K Sell
2,485
-1,677
-40% -$47.3K ﹤0.01% 1289
2021
Q3 		$114K Buy
+4,162
New +$121K ﹤0.01% 1310

Other funds holding RVMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Point72 Hong Kong's RVMD Position: Q3 2022 in Review

Point72 Hong Kong sold out of Revolution Medicines (RVMD) in Q3 2022, closing a stake of 1,998 shares — an estimated $39K sold.

Point72 Hong Kong first reported a position in RVMD in Q3 2021 and held it in 3 quarters. The position peaked at $114K in Q3 2021. 142 funds tracked by Wall St. Rank hold RVMD as of Q3 2022.

  • Point72 Hong Kong reported no remaining Revolution Medicines position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,998 Revolution Medicines shares in Q3 2022, an estimated $39K.
  • Point72 Hong Kong first reported a position in Revolution Medicines in Q3 2021 and held it in 3 quarters.
  • Point72 Hong Kong's Revolution Medicines position peaked at $114K in Q3 2021.
  • 142 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.